A Randomised, Double-blind, Placebo Controlled, Parallel Group Study in Healthy Adult Volunteers to Determine the Tolerability and Safety of Pyronaridine (PYR) Co-administered With Piperaquine (PQP) Under Fasted Conditions
Latest Information Update: 15 May 2024
At a glance
- Drugs Artesunate/pyronaridine (Primary) ; Dihydroartemisinin/piperaquine (Primary)
- Indications Malaria
- Focus Adverse reactions
- 25 Apr 2022 Status changed from recruiting to active, no longer recruiting.
- 06 Apr 2022 Planned End Date changed from 1 Apr 2022 to 1 Sep 2022.
- 06 Apr 2022 Planned primary completion date changed from 1 Apr 2022 to 1 May 2022.